Your session is about to expire
← Back to Search
Perampanel + Ketamine for Suicidal Thoughts
Study Summary
This trial looks at whether a drug called Ketamine can help treat depression and suicidal thoughts by affecting two types of receptors in the brain.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a neurological condition, but not migraines or mild head injury.I am currently being treated with Ketamine.I haven't donated more than 500 mL of blood or lost a similar amount in the last 56 days.I have used certain medical devices recently.I have been in psychotherapy for at least 4 weeks and plan to continue during the trial.I am currently seeing a mental health provider while considering Ketamine treatment.I can avoid caffeine, drugs, and alcohol for a week before each Ketamine treatment.I am not pregnant or breastfeeding and will use birth control, or I am unable to become pregnant.I have not taken monoamine oxidase inhibitors in the last 4 weeks.I have tried Ketamine before without feeling better.I have taken prescription or over-the-counter brain-affecting meds or supplements within the last week.I will receive Ketamine in the first week after my period starts, unless I have severe cramps.I have a history of HIV or Hepatitis B.My depression hasn't improved after trying at least one anti-depressant.I have been on the same depression medication and dose for at least 4 weeks.I am currently taking certain medications.
- Group 1: Placebo + Ketamine
- Group 2: Perampanel + Ketamine
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is eligibility for this experiment restricted to those under 35 years of age?
"To be eligible for this medical trial, participants must be under 65 years old and over the age of majority."
Could I potentially qualify to join this medical study?
"Eligible applicants must have a diagnosis of depression and be in the age range between 21 and 65. The trial is currently looking to sign-up approximately 30 individuals."
Does the Food and Drug Administration permit the combined use of Perampanel and Ketamine?
"Our safety rating for Perampanel + Ketamine is a 2, as we have evidence that it is safe to use but none demonstrating its efficacy."
Are new applicants being accepted for this trial?
"The clinical trial detailed on clinicaltrials.gov is no longer seeking applicants, as their last update was made March 14th 2023. However, there are presently 2491 other trials in need of volunteers around the world."
Share this study with friends
Copy Link
Messenger